SCHEMBL29515220

SCHEMBL29515220

Cc1cccc(COC(C)C)c1-c1nc(NS(=O)(=O)c2cccc(C(=O)O)c2)nc(Cl)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PTK2B Q14289 1/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ AKR1C3 P42330 3/20 0.40
▸ MEN1 O00255 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ACLY P53396 1/20 0.38
▸ CA1 P00915 2/20 0.37
▸ CA2 P00918 2/20 0.37
▸ SLC16A3 O15427 1/20 0.36
▸ F2 P00734 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ PRSS2 P07478 1/20 0.36
▸ PRSS3 P35030 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24331582 1.00 CASP3 (0.41) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL24331966 0.92 SLC40A1 (0.43) KMT2AMEN1ALDH1A1ACLYCA1
SCHEMBL29515225 0.92 SLC40A1 (0.43) KMT2AMEN1ALDH1A1ACLYCA1
SCHEMBL29515248 0.89 KDM4E (0.42) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL24331148 0.89 KDM4E (0.42) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL24330440 0.87 KDM4E (0.49) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL29515389 0.87 KDM4E (0.41) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL24330566 0.87 KDM4E (0.41) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL30588884 0.86 CASP3 (0.42) CASP3SENP8SENP7SENP6KDM4E
SCHEMBL26126074 0.86 CASP3 (0.42) CASP3SENP8SENP7SENP6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4504739-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2025-02-12 — — EP disclosed
WO-2023196429-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-12 — — WO disclosed
EP-4225761-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076620-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback